VERTEX PHARMACEUTICALS INC / MA Income Tax Expense 2010-2026 | VRTX
What is income tax expense?
Income tax expense is the total amount of income taxes a company owes to federal, state, and foreign governments.
What is VERTEX PHARMACEUTICALS INC / MA's current income tax expense?
VERTEX PHARMACEUTICALS INC / MA (VRTX) annual income tax expense for 2025 was $690.0M, a 12.00% decline from 2024. VERTEX PHARMACEUTICALS INC / MA income tax expense for the quarter ending March 31, 2026 was $221.5M.
What was VERTEX PHARMACEUTICALS INC / MA's income tax expense in 2024?
VERTEX PHARMACEUTICALS INC / MA annual income tax expense for 2024 was $784.1M, a 3.14% increase from 2023.
What was VERTEX PHARMACEUTICALS INC / MA's income tax expense in 2023?
VERTEX PHARMACEUTICALS INC / MA annual income tax expense for 2023 was $760.2M, a 16.50% decline from 2022.
What is VERTEX PHARMACEUTICALS INC / MA's 5-year income tax expense CAGR?
VERTEX PHARMACEUTICALS INC / MA income tax expense grew at a compound annual growth rate (CAGR) of 11.23% from FY2020 to FY2025, going from $405.2M to $690.0M over 5 years.
Year-over-year comparison from 10-K annual reports
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $690.0M | -12.0% | 10-K |
| FY2024 | $784.1M | +3.1% | 10-K |
| FY2023 | $760.2M | -16.5% | 10-K |
| FY2022 | $910.4M | +134.5% | 10-K |
| FY2021 | $388.3M | -4.2% | 10-K |
| FY2020 | $405.2M | +85.8% | 10-K |
| FY2019 | $218.1M | +114.7% | 10-K |
| FY2018 | $-1.49B | -1285.4% | 10-K |
| FY2017 | $-107.3M | -744.0% | 10-K |
| FY2016 | $16.7M | -45.1% | 10-K |
| FY2015 | $30.4M | +336.6% | 10-K |
| FY2014 | $7.0M | +105.7% | 10-K |
| FY2013 | $-122.4M | -44417.1% | 10-K |
| FY2012 | $-275,000 | -101.4% | 10-K |
| FY2011 | $19.3M | - | 10-K |
| FY2010 | $0 | - | 10-K |